Robotic StemCell BioTech Ltd.
Robotic StemCell BioTech Ltd. provides automated stem cell therapies and AI-powered culturing technology. Its core product is a fully automated AI stem cell culturing robot that reduces human oversight versus semi-automated systems. The technology leverages artificial intelligence and stem cell culturing within regenerative medicine. The company licenses intellectual property from Japanese hospitals and partners with Japanese national hospitals and health authorities to deliver therapy and medical tourism services. Markets include diabetes, cancers, immune disorders, anti-aging, and neurological diseases, with emphasis on advanced treatments available in Japan.
Robotic StemCell BioTech Ltd.
Robotic StemCell BioTech Ltd. provides automated stem cell therapies and AI-powered culturing technology. Its core product is a fully automated AI stem cell culturing robot that reduces human oversight versus semi-automated systems. The technology leverages artificial intelligence and stem cell culturing within regenerative medicine. The company licenses intellectual property from Japanese hospitals and partners with Japanese national hospitals and health authorities to deliver therapy and medical tourism services. Markets include diabetes, cancers, immune disorders, anti-aging, and neurological diseases, with emphasis on advanced treatments available in Japan.